T46.1X5D — Adverse effect of calcium-channel blockers, subsequent encounter
Is T46.1X5D billable?
Yes — T46.1X5D is billable for FY2027. T46.1X5D is a valid, billable ICD-10-CM code at the highest level of specificity in its branch. T46.1X5D may be submitted for encounters from October 1, 2026 through September 30, 2027.
T46.1X5D at a glance
| Code | T46.1X5D |
|---|---|
| Description | Adverse effect of calcium-channel blockers, subsequent encounter |
| Billable | Yes |
| Code set | ICD-10-CM FY2027 |
| Valid for encounters | October 1, 2026 – September 30, 2027 |
| 7th character "D" | subsequent encounter |
What does the 7th character "D" mean in T46.1X5D?
In T46.1X5D, the 7th character D means subsequent encounter. The 7th character is required for T46.1X5D to be a valid, complete code.
Same condition, different episode of care — switch the 7th character:
What Medicare edits apply to T46.1X5D?
The Medicare Code Editor screens inpatient claims before they are grouped. These edits name T46.1X5D directly.
CMS will reject this code as the principal diagnosis on an inpatient claim. It describes something other than the condition chiefly responsible for the admission.
Which MS-DRGs does T46.1X5D group to?
T46.1X5D sits in MDC 23 and helps define the logic of 2 MS-DRGs (version 44, FY2027). Which one a stay actually groups to also depends on procedures and secondary diagnoses.
- 949Aftercare with CC/MCCmedical
- 950Aftercare without CC/MCCmedical
Excludes1 — never code together — inherited from T36-T50
The conditions below can never be reported together with T46.1X5D on the same claim. An Excludes1 note means the two conditions cannot occur in the same patient, so reporting both is a coding error.
- toxic reaction to local anesthesia in pregnancy (O29.3-)
Excludes1 — never code together — inherited from T46
The conditions below can never be reported together with T46.1X5D on the same claim. An Excludes1 note means the two conditions cannot occur in the same patient, so reporting both is a coding error.
- poisoning by, adverse effect of and underdosing of metaraminol (T44.4)
Code first — inherited from T36-T50
The underlying condition below must be sequenced before T46.1X5D. T46.1X5D describes a manifestation and cannot be the principal or first-listed diagnosis.
Use additional code — inherited from Chapter 19
Report an additional code alongside T46.1X5D to fully describe the condition. T46.1X5D is sequenced first.
- code to identify any retained foreign body, if applicable (Z18.-)
Use additional code — inherited from T36-T50
Report an additional code alongside T46.1X5D to fully describe the condition. T46.1X5D is sequenced first.
Excludes2 — not included here — inherited from Chapter 19
The conditions below are not part of T46.1X5D, but a patient may have both at the same time. When documentation supports it, T46.1X5D and the excluded code may both be reported.
Excludes2 — not included here — inherited from T36-T50
The conditions below are not part of T46.1X5D, but a patient may have both at the same time. When documentation supports it, T46.1X5D and the excluded code may both be reported.
How long has T46.1X5D existed?
T46.1X5D has been in ICD-10-CM since at least FY2016, the earliest fiscal year on record here.
Derived from the official order files for FY2016–FY2026. FY2017 and FY2020 publish no order file, so those years are not covered.